Baird Medical Investment Holdings (BDMD) Accounts Payables (2023 - 2025)

Baird Medical Investment Holdings (BDMD) has 3 years of Accounts Payables data on file, last reported at $1.8 million in Q4 2025.

• On a quarterly basis, Accounts Payables rose 44.1% year-over-year to $1.8 million in Q4 2025; TTM through Dec 2025 was $1.8 million, a 44.1% increase from a year earlier, with the FY2025 full-year figure at $1.8 million, up 44.1% from the prior year.
• Accounts Payables for Q4 2025 stood at $1.8 million, down from $2.1 million in the prior quarter.
• Over the last five years, Accounts Payables for BDMD reached as high as $2.1 million in Q2 2025 and fell as low as $550188.0 in Q4 2023.
• Historically, Accounts Payables has averaged $1.4 million across 3 years, with a median of $1.5 million in 2024.
• Across the five-year window, Accounts Payables surged 127.68% in 2024 and jumped 44.1% in 2025, its largest moves.
• Year by year, Accounts Payables stood at $550188.0 in 2023, then jumped by 127.68% to $1.3 million in 2024, then surged by 44.1% to $1.8 million in 2025.
• Per Business Quant data, the three most recent Accounts Payables figures were $1.8 million in Q4 2025, $2.1 million in Q2 2025, and $1.3 million in Q4 2024.